[
    [
        {
            "time": "",
            "original_text": "康龙化成(03759.HK)委任楼柏良、楼小强及郑北为执行董事",
            "features": {
                "keywords": [
                    "康龙化成",
                    "执行董事",
                    "楼柏良",
                    "楼小强",
                    "郑北"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "康龙化成(03759.HK)委任楼柏良、楼小强及郑北为执行董事",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "【A股收盘综述】上证指数探底回升收跌0.24%，机构抱团股涨势依旧如火如荼",
            "features": {
                "keywords": [
                    "A股",
                    "上证指数",
                    "探底回升",
                    "机构抱团股"
                ],
                "sentiment_score": -0.2,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "金融"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【A股收盘综述】上证指数探底回升收跌0.24%，机构抱团股涨势依旧如火如荼",
                "Correlation": 3,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 4,
                "Duration": 2,
                "Entity_Density": 1,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 6,
                "Source_Recency": 10
            }
        },
        {
            "time": "",
            "original_text": "【浙商医药|点评】昭衍新药拟H股上市，岸外包业务的必然选择",
            "features": {
                "keywords": [
                    "昭衍新药",
                    "H股上市",
                    "外包业务"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "【浙商医药|点评】昭衍新药拟H股上市，岸外包业务的必然选择",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "康泰生物、智飞生物、康龙化成均创新高，复星医药大涨超6%",
            "features": {
                "keywords": [
                    "康泰生物",
                    "智飞生物",
                    "康龙化成",
                    "复星医药",
                    "创新高"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "康泰生物、智飞生物、康龙化成均创新高，复星医药大涨超6%",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 9,
                "Duration": 3,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 10
            }
        },
        {
            "time": "",
            "original_text": "【浙商医药|外包周报】A+H加速布局下医药CXO板块，是否还可以加仓？",
            "features": {
                "keywords": [
                    "浙商医药",
                    "外包周报",
                    "A+H布局",
                    "CXO板块"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "【浙商医药|外包周报】A+H加速布局下医药CXO板块，是否还可以加仓？",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "【浙商医药|周报】持续关注Q2基金重仓提升的制药创新产业链─医药行业周报",
            "features": {
                "keywords": [
                    "浙商医药",
                    "周报",
                    "Q2基金重仓",
                    "制药创新产业链"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "【浙商医药|周报】持续关注Q2基金重仓提升的制药创新产业链─医药行业周报",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 4,
                "Duration": 3,
                "Entity_Density": 2,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 5,
                "Source_Recency": 9
            }
        }
    ]
]